Skip to Content

Invesco Health Care Y GGHYX

Medalist Rating as of | See Invesco Investment Hub
  • NAV / 1-Day Return 41.13  /  +1.03 %
  • Total Assets 1.4 Bil
  • Adj. Expense Ratio
    0.810%
  • Expense Ratio 0.810%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield
  • Turnover 59%

USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0

Morningstar’s Analysis GGHYX

Will GGHYX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Invesco Health Care Y earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GGHYX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 46.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

8.39 109.5 Mil
Healthcare

UnitedHealth Group Inc

7.78 101.5 Mil
Healthcare

Boston Scientific Corp

5.11 66.7 Mil
Healthcare

McKesson Corp

4.05 52.8 Mil
Healthcare

Vertex Pharmaceuticals Inc

3.98 52.0 Mil
Healthcare

Regeneron Pharmaceuticals Inc

3.59 46.9 Mil
Healthcare

Merck & Co Inc

3.48 45.5 Mil
Healthcare

Stryker Corp

3.46 45.2 Mil
Healthcare

Intuitive Surgical Inc

3.21 41.9 Mil
Healthcare

Zoetis Inc Class A

3.14 41.0 Mil
Healthcare